Product Reports Resources Pricing Login Book a demo

Aortyx

Health Tech & Medtech · Teià, Spain · Founded 2018

Aortyx has developed a biomimetic bioresorbable adhesive patch to treat aortic dissections. It helps to stop false lumen blood flow, promotes natural repair and bio integration MoreLess

Developer of endovascular devices intended to treat vascular diseases. The company's devices focus on tissue regeneration by mimicking the aorta biomechanical environment and provide a suitable milieu for cell migration and proliferation in a bioresorbable platform that minimizes differences with the natural dynamics of the aorta, enabling professionals to treat vascular diseases in an efficient manner. Keywords: Healthcare Devices, Services, Supplies, Aortic Disease Treatment, Biomechanical Environment, Cell Migration, Cell Proliferation, Endovascular Device, Vascular Disease.

Company overview

Aortyx company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2018
Headquarters
Teià, Spain
Employees
30
Open positions
2
Dealroom signal
84.2
client focusb2btechnologyDeep TechtechnologyNanotechsub industryMedical Devicesbusiness modelManufacturingindustryHealthsectorSurgerysectorCardiology and cardiovascularsectorTissue EngineeringsectorRegenerative MedicinesectorSpinoutsectorEICsectorHeadstart (EIT Health)sectorEuropean Health Catapult (EIT Health)

Valuation & funding

Aortyx funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AEquity / VC Jun 2025 $15M $61M CDTI · Nara Capital · Ship2B Ventures · Banco Sabadell
SUPPORT PROGRAMOther financing Jan 2022 $0 EIT Health
EARLY VCEquity / VC Oct 2021 $0 EIC Fund
GRANTOther financing Oct 2021 $2.5M European Innovation Council
SEEDEquity / VC Apr 2021 $2.6M $11M Capital Cell
SUPPORT PROGRAMOther financing Jan 2021 EIT Health
DEBTDebt Jul 2020 Government of Spain. Ministry of Economy, Trade and Business
SUPPORT PROGRAMOther financing Jan 2020 EIT Health
GRANTOther financing Jan 2020 ENISA
GRANTOther financing Jan 2020 CDTI
Showing 10 recorded eventsUnlock the complete deal history →

Financials

Revenue, earnings and profit over time

Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.

YearRevenueGrowthEBITDAMarginProfitMargin
2026 $106K 0% −$567K -534.6% −$726K -684.2%
2025 $106K 0% −$567K -534.6% −$726K -684.2%
2024 $106K 0% −$567K -534.6% −$726K -684.2%
2023 $106K 0% −$567K -534.6%
2022 $106K 0% −$567K -534.6%
2021 $106K +1830.1% −$567K -534.6%
2020 $6K −$367 -6.7%
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Aortyx website traffic

Latest recorded traffic for Aortyx is 1.1K monthly website visits, up 39.2% over the last three months. Aortyx's team grew 11.1% over the past year.

Latest monthly visits1.1K 3-month web change+39.2% 1-year team growth+11.1%
Monthly website visits67 observations · Oct 2018–May 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Aortyx compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Aortyx's talent

Book a demo to see the people
Team profiled 13 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

18 investors on Aortyx's cap table

Sourced from Dealroom's funding and investor records.

Seed 7 investors entered at this stage
EIT Health
"la Caixa" Foundation
Genesis Biomed
ENISA
CDTI
Capital Cell
European Innovation Council
Series A 5 investors entered at this stage
EIC Fund
Ship2B Ventures
Nara Capital
Banco Sabadell
Clave Capital
Series B+ 1 investor entered at this stage
Government of Spain. Ministry of Economy, Trade and Business
Other known 5 additional known investors
August Pi i Sunyer Biomedical Research Institute
Barcelona Clinical Hospital
IQS School of Management
University of Barcelona
Marina Zaliznyak

Global footprint

Where Aortyx has talent and traffic

Workforce by country
2 countries with
team presence
🇪🇸 Spain96%
🇺🇸 United States4%
2 countries shown

In the news

Latest news about Aortyx

Recent press, funding announcements, and product moves mentioning Aortyx — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Aortyx

An AI-synthesized read of the highest-engagement posts about Aortyx on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Aortyx’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.